Table 3.
Measurements | 1 Dose (n = 18) |
2 Dose (n = 17) |
---|---|---|
SARS-CoV-2 S1 IgG ELISA (Ratio) | 11.2 ± 1.0 | 12.4 ± 1.4 |
pVNT (pVNT50) | 3333 ± 2322 | 2914 ± 2591 |
IFN-γ ELISpot (SFCs/2.5 × 105 cells) | 46.0 ± 44.3 | 26.1 ± 32.8 |
Measurements | 1 Dose (n = 18) |
2 Dose (n = 17) |
---|---|---|
SARS-CoV-2 S1 IgG ELISA (Ratio) | 11.2 ± 1.0 | 12.4 ± 1.4 |
pVNT (pVNT50) | 3333 ± 2322 | 2914 ± 2591 |
IFN-γ ELISpot (SFCs/2.5 × 105 cells) | 46.0 ± 44.3 | 26.1 ± 32.8 |